| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.12 |
£11.6B
| 1,405.00 | 2.78% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 2.08 |
£4.83B
| 244.20 | 0.66% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 0.97 |
£952.53M
| 234.50 | -0.85% |
| UPR |
Uniphar
|
AIM
| 0.00 |
£874.49M
| 336.00 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.24 |
£467.81M
| 216.50 | 3.10% |
| NIOX |
Niox Group
|
AIM
| 1.81 |
£289.17M
| 68.40 | |
| TSTL |
Tristel
|
Main Market
| 3.94 |
£171.89M
| 365.50 | 1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£115.62M
| 26.60 | 1.00% |
| SDI |
SDI Group
|
AIM
| |
£88.87M
| 83.00 | -1.50% |
| SPEC |
Inspecs Group
|
AIM
| |
£63.04M
| 63.49 | -0.30% |
| CREO |
Creo Medical Group
|
AIM
| |
£45.28M
| 11.10 | -0.80% |
| KMK |
Kromek Group
|
AIM
| |
£44.87M
| 6.78 | 8.70% |
| NCYT |
Novacyt SA
|
AIM
| |
£28.29M
| 39.20 | 4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£18.16M
| 20.25 | 0.60% |
| FAB |
Fusion Antibodies
|
AIM
| |
£15.34M
| 13.32 | 25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£14.23M
| 33.05 | -0.40% |
| GENI |
Genincode
|
AIM
| |
£8.32M
| 2.82 | 1.40% |
| RUA |
RUA Life Sciences
|
AIM
| |
£6.92M
| 12.15 | -6.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£5.36M
| 0.60 | -2.30% |
| MHC |
MyHealthChecked
|
AIM
| |
£4.42M
| 9.50 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£3.01M
| 0.75 | -1.10% |
| POLX |
Polarean Imaging
|
AIM
| |
£1.93M
| 0.15 | -3.20% |
| PYC |
Physiomics
|
AIM
| |
£1.29M
| 0.41 | -3.80% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |
| TRLS |
Trellus Health
|
AIM
| |
–
| 0.50 | 7.30% |